Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 4Active not recruiting 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 29Breast Neoplasms 17Neoplasms 14Neoplasm Metastasis 10Ovarian Neoplasms 9Carcinoma, Renal Cell 8Melanoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Colorectal Neoplasms 7Urinary Bladder Neoplasms 6Small Cell Lung Carcinoma 6Recurrence 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Thyroid Neoplasms 5Thyroid Cancer, Papillary 5Prostatic Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Pancreatic Neoplasms 5Lung Neoplasms 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Lymphoma 4Leukemia, Myeloid, Acute 4Urothelial Cancer 3Stomach Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3

Interventions

durvalumab 2Pemetrexed 2Cisplatin 2Carboplatin 2tremelimumab 1osimertinib 1Surgical Procedures, Operative 1Paclitaxel 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Has announcements × Carcinoma × Clear all
NCT03703297 2025-11-21

ADRIATIC

AstraZeneca

Phase 3 Active not recruiting
730 enrolled 19 charts 1 FDA
Thoracic

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

NCT04035486 2025-10-10

FLAURA2

AstraZeneca

Phase 3 Active not recruiting
587 enrolled 44 charts 1 FDA
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03800134 2025-06-11

AEGEAN

AstraZeneca

Phase 3 Active not recruiting
825 enrolled 1 FDA
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡